基于T细胞枯竭相关基因的系统分析确定CD38为卵巢癌的新疗法标

Tianming Shi1,2, Rongrong Yan1,2, M I Han1,2

  • 1Department of Gynecologic Oncology, The International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Oncology research
|July 7, 2023
PubMed
概括

卵巢癌 (OV) 中的T细胞耗尽异质性影响患者的预后. 一个新的T细胞相关基因评分 (TRS) 有效地预测了存活率,指导了针对这种异质瘤的向治疗.